early-stage
Last year, Claremont Creek Ventures was exposed to over 500 startup ideas and entrepreneurs. As is probably typical in most early stage technology Venture Capitalists, we ultimately invest in less than 1% of the deals we see. That means we are saying “no” at least 99 times for every time we ultimately say “yes”. It […]
Read MoreOctober 6, 2010 source: PrivateEquityCentral.net (registration required for site access) This interview with Ted Driscoll was originally published on the Private Equity Central website. The Future is Now Bionic limbs may sound like something out of the future, but it is not. It is here. Now. Claremont Creek Ventures, a firm with $310 million in […]
Read MoreWhat a difference a year makes. In 2009, with the nation’s economic storm raging with gale-force winds, most venture capitalists pulled in their horns, trimmed the size of their startup portfolios and only rarely invested in new startups, whether they were promising or not. When they did invest, it was mostly in later-stage rounds. Some […]
Read MoreAndy Grove takes Thomas Friedman, a columnist for the New York Times to task in Grove’s recent Business Week article “How America Creates Jobs”. Andy Grove argues that Friedman is wrong in claiming in his column that “if Washington wants to create jobs it should back startups”. Grove states that startups are wonderful things, but […]
Read More
February 10, 2010 source: Vator.tv Claremont Creek Ventures is one of the only VC firms in the East Bay. That’s a good thing for Nat Goldhaber, one of the managing directors at the Oakland-based firm. Deal flow in clean tech is accelerating Claremont Creek Ventures ‘LifeCycle’ venturing model attracts a solid flow of energy deals Claremont […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.